Where to Find Publicly Disclosed Regulatory Precedent in the EU, US and Canada

Posted 01 February 2017 By Linda Bowen, MS, RAC, João Duarte, MPharm

placeholder+image This article provides a better understanding of the types of information available from regulatory authorities by outlining sources of precedent focused on development activities, regulatory submission and evaluation, and approval and post-authorization activities.

Share this article:

Categories: Biologics and biotechnology, Drugs, Clinical, Labeling, Regulatory strategy, Submission and registration, Features, US, Europe, FDA, EMA

Tags:

Regulatory Exchange: Latest Updates From the Community